These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 34475272)

  • 1. Inhibition of Cytochrome P450 Enzymes by Drugs-Molecular Basis and Practical Applications.
    Guengerich FP
    Biomol Ther (Seoul); 2022 Jan; 30(1):1-18. PubMed ID: 34475272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roles of cytochrome P450 enzymes in pharmacology and toxicology: Past, present, and future.
    Guengerich FP
    Adv Pharmacol; 2022; 95():1-47. PubMed ID: 35953152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of Individual Human Cytochrome P450 Enzymes in Drug Metabolism.
    Guengerich FP
    Pharmacol Rev; 2024 Oct; 76(6):1104-1132. PubMed ID: 39054072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of cytochrome P450 enzymes in drug-drug interactions.
    Guengerich FP
    Adv Pharmacol; 1997; 43():7-35. PubMed ID: 9342171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A history of the roles of cytochrome P450 enzymes in the toxicity of drugs.
    Guengerich FP
    Toxicol Res; 2021 Jan; 37(1):1-23. PubMed ID: 32837681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism and interactions of Ivermectin with human cytochrome P450 enzymes and drug transporters, possible adverse and toxic effects.
    Rendic SP
    Arch Toxicol; 2021 May; 95(5):1535-1546. PubMed ID: 33719007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition and induction of cytochrome P450 and the clinical implications.
    Lin JH; Lu AY
    Clin Pharmacokinet; 1998 Nov; 35(5):361-90. PubMed ID: 9839089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From electrochemistry to enzyme kinetics of cytochrome P450.
    Shumyantseva VV; Kuzikov AV; Masamrekh RA; Bulko TV; Archakov AI
    Biosens Bioelectron; 2018 Dec; 121():192-204. PubMed ID: 30218927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism and Interactions of Chloroquine and Hydroxychloroquine with Human Cytochrome P450 Enzymes and Drug Transporters.
    Rendic S; Guengerich FP
    Curr Drug Metab; 2020; 21(14):1127-1135. PubMed ID: 33292107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro inhibitory mechanisms and molecular docking of 1'-S-1'-acetoxychavicol acetate on human cytochrome P450 enzymes.
    Haque AKMM; Leong KH; Lo YL; Awang K; Nagoor NH
    Phytomedicine; 2017 Jul; 31():1-9. PubMed ID: 28606510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mechanisms of interactions of psychotropic drugs with liver and brain cytochrome P450 and their significance for drug effect and drug-drug interactions.
    Daniel WA; Bromek E; Danek PJ; Haduch A
    Biochem Pharmacol; 2022 May; 199():115006. PubMed ID: 35314167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytochrome P450 Structure, Function and Clinical Significance: A Review.
    Manikandan P; Nagini S
    Curr Drug Targets; 2018; 19(1):38-54. PubMed ID: 28124606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human cytochrome P450 enzymes bind drugs and other substrates mainly through conformational-selection modes.
    Guengerich FP; Wilkey CJ; Phan TTN
    J Biol Chem; 2019 Jul; 294(28):10928-10941. PubMed ID: 31147443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytochrome P450 enzymes: a review on drug metabolizing enzyme inhibition studies in drug discovery and development.
    Rao Gajula SN; Pillai MS; Samanthula G; Sonti R
    Bioanalysis; 2021 Sep; ():. PubMed ID: 34517735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal drug metabolism in humans: the potential for drug-endobiotic interactions involving cytochrome P450 (CYP) and UDP-glucuronosyltransferase (UGT).
    Knights KM; Rowland A; Miners JO
    Br J Clin Pharmacol; 2013 Oct; 76(4):587-602. PubMed ID: 23362865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism-based inactivation of cytochrome P450 enzymes: chemical mechanisms, structure-activity relationships and relationship to clinical drug-drug interactions and idiosyncratic adverse drug reactions.
    Kalgutkar AS; Obach RS; Maurer TS
    Curr Drug Metab; 2007 Jun; 8(5):407-47. PubMed ID: 17584015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism-based inactivation of cytochrome P450 enzymes by natural products based on metabolic activation.
    Zhang T; Rao J; Li W; Wang K; Qiu F
    Drug Metab Rev; 2020 Nov; 52(4):501-530. PubMed ID: 33043714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methodologies for investigating drug metabolism at the early drug discovery stage: prediction of hepatic drug clearance and P450 contribution.
    Emoto C; Murayama N; Rostami-Hodjegan A; Yamazaki H
    Curr Drug Metab; 2010 Oct; 11(8):678-85. PubMed ID: 20973757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Herbal interactions involving cytochrome p450 enzymes: a mini review.
    Delgoda R; Westlake AC
    Toxicol Rev; 2004; 23(4):239-49. PubMed ID: 15898829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficient heterologous expression of cytochrome P450 enzymes in microorganisms for the biosynthesis of natural products.
    Hu B; Zhao X; Wang E; Zhou J; Li J; Chen J; Du G
    Crit Rev Biotechnol; 2023 Mar; 43(2):227-241. PubMed ID: 35129020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.